Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Global Clinical Microbiology Instruments and Reagents Market to Reach $6.1 Billion by 2027

Published

on

New York, July 28, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Clinical Microbiology Instruments and Reagents Industry” – https://www.reportlinker.com/p05957366/?utm_source=GNW
1 Billion by 2027, growing at aCAGR of 6.4% over the period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record 5.3% CAGR and reach US$2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents segment is readjusted to a revised 7.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.5 Billion, While China is Forecast to Grow at 7.7% CAGR

The Clinical Microbiology Instruments and Reagents market in the U.S. is estimated at US$1.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$305.3 Million by the year 2027 trailing a CAGR of 7.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.2% and 6.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.3% CAGR.

Select Competitors (Total 59 Featured)

  • 3M
  • Abbott Laboratories
  • Agilent Technologies
  • Becton, Dickinson and Company
  • Biomérieux
  • Bio-Rad Laboratories, Inc
  • Bruker Corporation
  • Cepheid Inc
  • Danaher Corporation
  • Eiken Chemical Co., Ltd.
  • Hologic, Inc
  • NEOGEN Corporation
  • QIAGEN GmbH
  • Hoff Man Roche
    Diagnostics Division
  • Shimadzu Corporation
  • Thermo Fisher Scientific

Read the full report: https://www.reportlinker.com/p05957366/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

Advertisement
Stake.com

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
EXHIBIT 1: The World of Clinical Microbiology Gains Sudden
Prominence as Scientists Mobilize United Efforts to Find Ways
to Detect, Treat & Vaccinate People Against the Novel
Coronavirus: Global Scale of Daily Testing Vs Confirmed
Cases Per Million
Clinical Microbiology: An Introduction
Outlook: Evolutionary Battle against Microbes Drives Market Future
Instant Detection of Pathogens : A New Epoch in the Fight for
Survival
Reagents Account for Major Share
Asia-Pacific Drives Future Growth
Recent Market Activity
World Brands

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Microbiology Laboratories Switch to Automation to Push Yields
EXHIBIT 2: World Laboratory Automation Market in US$ Billion
for Years 2018, 2020, 2022, 2024 & 2026
Clinical Microbiology Market Benefits from Digitalization and
Robotization Trend
Integration of Clinical Microbiology with Cloud Computing
Artificial Intelligence Holds Positive Implications for
Automation of Clinical Microbiology
Advancements in Molecular Diagnostics Drive Market Growth
Emerging Technologies in Clinical Microbiology Diagnostics Aim
at Faster Diagnosis
Technological Advances Crucial to Sustain Future Market Growth
Rapid Diagnostics Bring in a Transformation
Automated and Rapid Microbiological Tests Revolutionize
Microbiological Testing
Traditional Rapid Microbiological Tests Make Way for New, Probe
Tests
Antibiotic Resistant Bacteria Throws the Spotlight on Microbial
Testing
Research in Stem Cell Technology, and Regenerative Medicine
Expand Growth Opportunities
EXHIBIT 3: Stem Cell Banking Global Market Estimates and
Forecasts in US$ Billion: 2020, 2022 & 2024
Greater Number of Tests for HIV and Sexually Transmitted
Diseases Amplify Growth
EXHIBIT 4: Global HIV Prevalence: Number of People Living with
AIDs (in Thousands) by Region for 2018
EXHIBIT 5: Number of AIDS-Related Deaths (in Thousands) by
Region for 2018
Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer
Disease
Home HIV Testing Emerges as a Lucrative Option
Increasing Incidence of Infectious Diseases Drives Growth
EXHIBIT 6: Infectious Diseases Remain Major Cause of Death in
Under Developed Regions: Breakdown of Leading Causes of Death
in Sub-Saharan Africa (in %)
EXHIBIT 7: Infectious Diseases Related Mortality High Among
Children Below 5 Years: Breakdown of Leading Causes of Death
in Children Below 5 Years (in %)
Increasing Prevalence of Respiratory Infections Drive Growth
EXHIBIT 8: Global Number of Deaths Caused Due to Communicable
Diseases (In 000s)
Influenza Boosts Rapid Test Prospects
EXHIBIT 9: Flu Related CDC Estimates from October 2019-April4,
2020
Rise in Prevalence of COPD Augments Demand
EXHIBIT 10: Global Prevalence of COPD by Age Group: Percentage
of Men and Women Affected by the Condition
Rise in Pollution Levels Trigger Increase in Respiratory Diseases
EXHIBIT 11: World Ranking of Most Polluted Countries: 2019
EXHIBIT 12: Percentage Share Breakdown of Global Deaths Linked
to Air Pollution
Increase in Healthcare Spending in Emerging Markets to Propel
Demand
EXHIBIT 13: World Healthcare Expenditure (In US$ Billion) for
the Years 2017-2023
Demographic Shifts & Societal Changes Drive Demand for Test
Volumes
EXHIBIT 14: Elderly Healthcare Expenditure as a % of GDP
EXHIBIT 15: Global Population Statistics for the 65+ Age Group
in Million by Geographic Region for the Years 2019, 2025, 2035
and 2050
EXHIBIT 10: Life Expectancy at Age 60 and 80 Years: (2010-2015
), (2020-2025) & (2045-2050)

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Geographic Region –
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Clinical Microbiology
Instruments and Reagents by Geographic Region – USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Advertisement
Stake.com

Table 3: World 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Geographic Region – Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Instruments by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Instruments by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Instruments by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Reagents by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Advertisement
Stake.com

Table 8: World Historic Review for Reagents by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Reagents by Geographic
Region – Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Respiratory
Diseases by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Respiratory Diseases by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Respiratory Diseases by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Advertisement
Stake.com

Table 13: World Current & Future Analysis for Bloodstream
Infections by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Bloodstream Infections by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Bloodstream Infections
by Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Gastrointestinal
Diseases by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Gastrointestinal Diseases
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Advertisement
Stake.com

Table 18: World 15-Year Perspective for Gastrointestinal
Diseases by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 19: World Current & Future Analysis for Sexually
Transmitted Diseases by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Sexually Transmitted
Diseases by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Sexually Transmitted
Diseases by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 22: World Current & Future Analysis for Urinary Tract
Infections by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Advertisement
Stake.com

Table 23: World Historic Review for Urinary Tract Infections by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Urinary Tract
Infections by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 25: World Current & Future Analysis for Other Disease
Areas by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 26: World Historic Review for Other Disease Areas by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Other Disease Areas by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Advertisement
Stake.com

Table 28: World Current & Future Analysis for Hospitals &
Diagnostic Centers by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 29: World Historic Review for Hospitals & Diagnostic
Centers by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Hospitals & Diagnostic
Centers by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 31: World Current & Future Analysis for Custom Lab
Service Providers by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 32: World Historic Review for Custom Lab Service
Providers by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Advertisement
Stake.com

Table 33: World 15-Year Perspective for Custom Lab Service
Providers by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 34: World Current & Future Analysis for Academic &
Research Institutes by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 35: World Historic Review for Academic & Research
Institutes by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 36: World 15-Year Perspective for Academic & Research
Institutes by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

III. MARKET ANALYSIS

Advertisement
Stake.com

UNITED STATES
Market Overview
EXHIBIT 16: Healthcare Spending as a % of GDP in the US: 2010-2020
COVID-19 Pandemic: US Emerges as a Major Market for COVID-19 Tests
Table 37: USA Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Product – Instruments
and Reagents – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 38: USA Historic Review for Clinical Microbiology
Instruments and Reagents by Product – Instruments and Reagents
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 39: USA 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Product – Percentage Breakdown of
Value Sales for Instruments and Reagents for the Years 2012,
2020 & 2027

Table 40: USA Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Disease Area –
Respiratory Diseases, Bloodstream Infections, Gastrointestinal
Diseases, Sexually Transmitted Diseases, Urinary Tract
Infections and Other Disease Areas – Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 41: USA Historic Review for Clinical Microbiology
Instruments and Reagents by Disease Area – Respiratory
Diseases, Bloodstream Infections, Gastrointestinal Diseases,
Sexually Transmitted Diseases, Urinary Tract Infections and
Other Disease Areas Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Advertisement
Stake.com

Table 42: USA 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Disease Area – Percentage Breakdown
of Value Sales for Respiratory Diseases, Bloodstream
Infections, Gastrointestinal Diseases, Sexually Transmitted
Diseases, Urinary Tract Infections and Other Disease Areas for
the Years 2012, 2020 & 2027

Table 43: USA Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by End-Use – Hospitals &
Diagnostic Centers, Custom Lab Service Providers and Academic &
Research Institutes – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 44: USA Historic Review for Clinical Microbiology
Instruments and Reagents by End-Use – Hospitals & Diagnostic
Centers, Custom Lab Service Providers and Academic & Research
Institutes Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 45: USA 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by End-Use – Percentage Breakdown of
Value Sales for Hospitals & Diagnostic Centers, Custom Lab
Service Providers and Academic & Research Institutes for the
Years 2012, 2020 & 2027

CANADA
Table 46: Canada Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Product – Instruments
and Reagents – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Advertisement
Stake.com

Table 47: Canada Historic Review for Clinical Microbiology
Instruments and Reagents by Product – Instruments and Reagents
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 48: Canada 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Product – Percentage Breakdown of
Value Sales for Instruments and Reagents for the Years 2012,
2020 & 2027

Table 49: Canada Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Disease Area –
Respiratory Diseases, Bloodstream Infections, Gastrointestinal
Diseases, Sexually Transmitted Diseases, Urinary Tract
Infections and Other Disease Areas – Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 50: Canada Historic Review for Clinical Microbiology
Instruments and Reagents by Disease Area – Respiratory
Diseases, Bloodstream Infections, Gastrointestinal Diseases,
Sexually Transmitted Diseases, Urinary Tract Infections and
Other Disease Areas Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 51: Canada 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Disease Area – Percentage Breakdown
of Value Sales for Respiratory Diseases, Bloodstream
Infections, Gastrointestinal Diseases, Sexually Transmitted
Diseases, Urinary Tract Infections and Other Disease Areas for
the Years 2012, 2020 & 2027

Advertisement
Stake.com

Table 52: Canada Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by End-Use – Hospitals &
Diagnostic Centers, Custom Lab Service Providers and Academic &
Research Institutes – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 53: Canada Historic Review for Clinical Microbiology
Instruments and Reagents by End-Use – Hospitals & Diagnostic
Centers, Custom Lab Service Providers and Academic & Research
Institutes Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 54: Canada 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by End-Use – Percentage Breakdown of
Value Sales for Hospitals & Diagnostic Centers, Custom Lab
Service Providers and Academic & Research Institutes for the
Years 2012, 2020 & 2027

JAPAN
Market Overview
Covid-19 Testing Market in Japan
Demographics Drive Market Growth
EXHIBIT 17: Breakdown of Population by Age Group in Japan:
2010, 2020, and 2025
Market Analytics
Table 55: Japan Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Product – Instruments
and Reagents – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 56: Japan Historic Review for Clinical Microbiology
Instruments and Reagents by Product – Instruments and Reagents
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Advertisement
Stake.com

Table 57: Japan 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Product – Percentage Breakdown of
Value Sales for Instruments and Reagents for the Years 2012,
2020 & 2027

Table 58: Japan Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Disease Area –
Respiratory Diseases, Bloodstream Infections, Gastrointestinal
Diseases, Sexually Transmitted Diseases, Urinary Tract
Infections and Other Disease Areas – Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 59: Japan Historic Review for Clinical Microbiology
Instruments and Reagents by Disease Area – Respiratory
Diseases, Bloodstream Infections, Gastrointestinal Diseases,
Sexually Transmitted Diseases, Urinary Tract Infections and
Other Disease Areas Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 60: Japan 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Disease Area – Percentage Breakdown
of Value Sales for Respiratory Diseases, Bloodstream
Infections, Gastrointestinal Diseases, Sexually Transmitted
Diseases, Urinary Tract Infections and Other Disease Areas for
the Years 2012, 2020 & 2027

Table 61: Japan Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by End-Use – Hospitals &
Diagnostic Centers, Custom Lab Service Providers and Academic &
Research Institutes – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Advertisement
Stake.com

Table 62: Japan Historic Review for Clinical Microbiology
Instruments and Reagents by End-Use – Hospitals & Diagnostic
Centers, Custom Lab Service Providers and Academic & Research
Institutes Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 63: Japan 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by End-Use – Percentage Breakdown of
Value Sales for Hospitals & Diagnostic Centers, Custom Lab
Service Providers and Academic & Research Institutes for the
Years 2012, 2020 & 2027

CHINA
Market Overview
Covid-19 Testing Market
Market Analytics
Table 64: China Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Product – Instruments
and Reagents – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 65: China Historic Review for Clinical Microbiology
Instruments and Reagents by Product – Instruments and Reagents
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 66: China 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Product – Percentage Breakdown of
Value Sales for Instruments and Reagents for the Years 2012,
2020 & 2027

Advertisement
Stake.com

Table 67: China Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Disease Area –
Respiratory Diseases, Bloodstream Infections, Gastrointestinal
Diseases, Sexually Transmitted Diseases, Urinary Tract
Infections and Other Disease Areas – Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 68: China Historic Review for Clinical Microbiology
Instruments and Reagents by Disease Area – Respiratory
Diseases, Bloodstream Infections, Gastrointestinal Diseases,
Sexually Transmitted Diseases, Urinary Tract Infections and
Other Disease Areas Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 69: China 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Disease Area – Percentage Breakdown
of Value Sales for Respiratory Diseases, Bloodstream
Infections, Gastrointestinal Diseases, Sexually Transmitted
Diseases, Urinary Tract Infections and Other Disease Areas for
the Years 2012, 2020 & 2027

Table 70: China Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by End-Use – Hospitals &
Diagnostic Centers, Custom Lab Service Providers and Academic &
Research Institutes – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 71: China Historic Review for Clinical Microbiology
Instruments and Reagents by End-Use – Hospitals & Diagnostic
Centers, Custom Lab Service Providers and Academic & Research
Institutes Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Advertisement
Stake.com

Table 72: China 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by End-Use – Percentage Breakdown of
Value Sales for Hospitals & Diagnostic Centers, Custom Lab
Service Providers and Academic & Research Institutes for the
Years 2012, 2020 & 2027

EUROPE
Market Overview
COVID-19 Pandemic Propels Demand
Growth in Clinical Diagnostics Automation
Rise in Automated, and Rapid Tests in Clinical Applications
Ageing Demography: An Opportunity Indicator
Market Analytics
Table 73: Europe Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Geographic Region –
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 74: Europe Historic Review for Clinical Microbiology
Instruments and Reagents by Geographic Region – France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 75: Europe 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Geographic Region – Percentage
Breakdown of Value Sales for France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets for Years 2012, 2020 & 2027

Table 76: Europe Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Product – Instruments
and Reagents – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Advertisement
Stake.com

Table 77: Europe Historic Review for Clinical Microbiology
Instruments and Reagents by Product – Instruments and Reagents
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 78: Europe 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Product – Percentage Breakdown of
Value Sales for Instruments and Reagents for the Years 2012,
2020 & 2027

Table 79: Europe Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Disease Area –
Respiratory Diseases, Bloodstream Infections, Gastrointestinal
Diseases, Sexually Transmitted Diseases, Urinary Tract
Infections and Other Disease Areas – Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 80: Europe Historic Review for Clinical Microbiology
Instruments and Reagents by Disease Area – Respiratory
Diseases, Bloodstream Infections, Gastrointestinal Diseases,
Sexually Transmitted Diseases, Urinary Tract Infections and
Other Disease Areas Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 81: Europe 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Disease Area – Percentage Breakdown
of Value Sales for Respiratory Diseases, Bloodstream
Infections, Gastrointestinal Diseases, Sexually Transmitted
Diseases, Urinary Tract Infections and Other Disease Areas for
the Years 2012, 2020 & 2027

Advertisement
Stake.com

Table 82: Europe Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by End-Use – Hospitals &
Diagnostic Centers, Custom Lab Service Providers and Academic &
Research Institutes – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 83: Europe Historic Review for Clinical Microbiology
Instruments and Reagents by End-Use – Hospitals & Diagnostic
Centers, Custom Lab Service Providers and Academic & Research
Institutes Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 84: Europe 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by End-Use – Percentage Breakdown of
Value Sales for Hospitals & Diagnostic Centers, Custom Lab
Service Providers and Academic & Research Institutes for the
Years 2012, 2020 & 2027

FRANCE
Table 85: France Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Product – Instruments
and Reagents – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 86: France Historic Review for Clinical Microbiology
Instruments and Reagents by Product – Instruments and Reagents
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Advertisement
Stake.com

Table 87: France 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Product – Percentage Breakdown of
Value Sales for Instruments and Reagents for the Years 2012,
2020 & 2027

Table 88: France Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Disease Area –
Respiratory Diseases, Bloodstream Infections, Gastrointestinal
Diseases, Sexually Transmitted Diseases, Urinary Tract
Infections and Other Disease Areas – Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 89: France Historic Review for Clinical Microbiology
Instruments and Reagents by Disease Area – Respiratory
Diseases, Bloodstream Infections, Gastrointestinal Diseases,
Sexually Transmitted Diseases, Urinary Tract Infections and
Other Disease Areas Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 90: France 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Disease Area – Percentage Breakdown
of Value Sales for Respiratory Diseases, Bloodstream
Infections, Gastrointestinal Diseases, Sexually Transmitted
Diseases, Urinary Tract Infections and Other Disease Areas for
the Years 2012, 2020 & 2027

Table 91: France Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by End-Use – Hospitals &
Diagnostic Centers, Custom Lab Service Providers and Academic &
Research Institutes – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Advertisement
Stake.com

Table 92: France Historic Review for Clinical Microbiology
Instruments and Reagents by End-Use – Hospitals & Diagnostic
Centers, Custom Lab Service Providers and Academic & Research
Institutes Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 93: France 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by End-Use – Percentage Breakdown of
Value Sales for Hospitals & Diagnostic Centers, Custom Lab
Service Providers and Academic & Research Institutes for the
Years 2012, 2020 & 2027

GERMANY
Table 94: Germany Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Product – Instruments
and Reagents – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 95: Germany Historic Review for Clinical Microbiology
Instruments and Reagents by Product – Instruments and Reagents
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 96: Germany 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Product – Percentage Breakdown of
Value Sales for Instruments and Reagents for the Years 2012,
2020 & 2027

Advertisement
Stake.com

Table 97: Germany Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Disease Area –
Respiratory Diseases, Bloodstream Infections, Gastrointestinal
Diseases, Sexually Transmitted Diseases, Urinary Tract
Infections and Other Disease Areas – Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 98: Germany Historic Review for Clinical Microbiology
Instruments and Reagents by Disease Area – Respiratory
Diseases, Bloodstream Infections, Gastrointestinal Diseases,
Sexually Transmitted Diseases, Urinary Tract Infections and
Other Disease Areas Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05957366/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

Advertisement
Stake.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Metz, in Partnership with AI TECH, Introduces Advanced Interactive Flat Panel to Middle East Market

Published

on

metz,-in-partnership-with-ai-tech,-introduces-advanced-interactive-flat-panel-to-middle-east-market

SHENZHEN, China, June 17, 2024 /PRNewswire/ — METZ Display, a sub-brand of SKYWORTH and a provider of innovative interactive displays for education and business. The announcement of Artificial Intelligence Technologies LLC Dubai as the authorized exclusive distributor for the UAE market as well as the Oman, Qatar, and Bahrain markets marks a significant expansion for METZ Display. By partnering with a trusted distributor like Artificial Intelligence Technologies, METZ is strategically positioning itself to deliver its full range of smart education and smart conference room applications across these regions. This move not only strengthens METZ’s presence in the Middle East but also underscores its commitment to providing innovative interactive displays tailored for both educational and business environments.

Based on the 16 years of R&D and business experience in the IFPD market from SKYWORTH, METZ Display fully inherited its technology and has introduced several interactive displays in the education and business sectors that provide a highly immersive environment and user-friendly experience since 2022, such as the all-in-one LCD.
Mr. Summer Deng METZ  Sales & Marketing Head of MEA, said: ” The IFPD market in MEA is expected to see rapid growth over the next couple of years. The partnership with Artificial Intelligence Technologies LLC, a business entity to promote AI & AV Products, Tools, and services in the United Arab Emirates & Middle East Region will take METZ Display to another new level. We are confident to further develop our quality products and service!”
METZ Display is expanding its reach into the UAE market through Artificial Intelligence Technologies LLC Dubai as its authorized distributor.
The introduction of the METZ K Pro Series, particularly the EDLA Certified collaborative display, in the MEA Region highlights their commitment to providing innovative interactive display solutions for both education and business sectors. This move could potentially enhance learning and collaboration experiences in the region.
Mr. Harold Fernandes, the Managing Director of Artificial Intelligence Technologies, seems quite enthusiastic about the partnership with METZ Display. His emphasis on the versatility of METZ’s portfolio, applicable across various sectors such as education and business, reflects a keen understanding of the market’s needs. By highlighting the engaging experiences offered by METZ Display products, he’s underlining the potential benefits for resellers and end-users alike. This partnership seems poised to bring innovative solutions to the UAE market.
About METZ Display
With Skyworth, one of the world’s largest TV companies, and Metz, one of the oldest German manufacturers, METZ Display creates high-quality educational and business applications that make state-of-the-art screen technology available to everyone by combining their strengths and 80 years of experience.
About Artificial Intelligence Technologies LLC
Artificial Intelligence Technologies LLC, Is established as a business entity to promote AI & AV Products, and complete AV Solution, Tools & Services in the United Arab Emirates & Middle East Region. Visit the website at https://ai-tech.ai/ 
Phone: +971 4299 0544Email: [email protected]: www.ai-tech.ai
Photo – https://mma.prnewswire.com/media/2439536/Skyworth_Optoelectronics_Technology.jpg

View original content:https://www.prnewswire.co.uk/news-releases/metz-in-partnership-with-ai-tech-introduces-advanced-interactive-flat-panel-to-middle-east-market-302173734.html

Continue Reading

Artificial Intelligence

Complyport’s new AI tool – ViCA.Chat – set to revolutionise compliance support services

Published

on

complyport’s-new-ai-tool-–-vica.chat-–-set-to-revolutionise-compliance-support-services

LONDON, June 14, 2024 /PRNewswire/ — ViCA.Chat, the Virtual Compliance Assistant powered by AI technology, is set to transform regulatory compliance consulting. Developed by ComplyMAP Group’s AI engineers and Complyport’s compliance consulting teams, ViCA redefines compliance support services and propels governance, risk and compliance consulting into a new era of innovation. 

Offering real-time assistance across a vast array of UK and EU regulatory frameworks, ViCA delivers unparalleled efficiency, detail and precision in disentangling and dealing with complicated regulatory frameworks.
The key differentiator of ViCA is its specialised and purposely constructed unique databases that leverage Complyport’s 22 years of regulatory expertise, combined with tailored AI training tools, enabling ViCA to operate as an experienced compliance consultant. A dedicated human support team continuously improves and updates ViCA’s knowledge and responses through a feedback loop process and quality assurance sessions. This powerful symbiosis of AI and human expertise sets ViCA apart and ensures businesses have the latest regulatory information instantaneously and seamlessly.
As a result, ViCA’s specialised regulatory database goes beyond readily available online resources which feature into traditional AI tools. ViCA offers exclusive insights, proprietary regulatory interpretations, historical data, bespoke and purposely structured compliance documentation and templates. With advanced scraping capabilities, ViCA also extracts relevant data from selected websites and publicly available information, ensuring an up-to-date and comprehensive understanding of compliance requirements across industries.
From agile fintech startups to established law firms, financial institutions, regulatory bodies, insurance providers, as well as compliance consultants, ViCA seamlessly adapts to unique compliance needs. Its user-friendly interface ensures navigating and analysing regulatory data is swift and intuitive, streamlining the compliance workflow.
“ViCA is a game-changer in how regulatory compliance advice will be provided in the future”, commented Luis Parra, Managing Director of ViCA. “With ViCA, compliance insights become available to all. No longer are regulated firms and responsible people overly dependent on advisors and compliance consultants. Through ViCA, the financial system will not only meet but exceed regulatory standards. Moreover, the level of information made available to the public will benefit society as a whole, in its interactions with the financial services sector.”
Among ViCA’s revolutionary features is its cost-effective model, allowing businesses to significantly reduce reliance on traditional spending with external consultants and advisors.
Visit ViCA.Chat to experience the future of compliance support.
Contact:
Name: Luis ParraTitle: Managing DirectorCompany: Vica.ChatTelephone: +44 20 7399 4980 Email: [email protected]
About ViCA.Chat:
ViCA.Chat is a revolutionary Virtual Compliance Assistant powered by cutting-edge AI technology, designed to demystify the complexities of regulatory compliance. Utilising Complyport’s 22 years of regulatory expertise, ViCA offers real-time assistance and guidance across a wide range of regulatory frameworks, setting a new standard for efficiency and precision in compliance support. From fintech start-ups to established law firms, financial services institutions, regulators, regulatory firms, compliance consultants and insurance firms, ViCA caters to the diverse needs of professionals across all levels in the broader UK financial services sector.
Visit ViCA.Chat to learn more.
Logo – https://mma.prnewswire.com/media/2439008/ViCA_Logo.jpg

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/complyports-new-ai-tool—vicachat—set-to-revolutionise-compliance-support-services-302173182.html

Continue Reading

Artificial Intelligence

LoRa and LoRaWAN IoT Market worth $32.7 billion by 2029- Exclusive Report by MarketsandMarkets™

Published

on

lora-and-lorawan-iot-market-worth-$32.7-billion-by-2029-exclusive-report-by-marketsandmarkets™

CHICAGO, June 14, 2024 /PRNewswire/ — The LoRa and LoRaWAN IoT Market is expected to reach USD 32.7 billion by 2029 from USD 8.0 billion in 2024, at a Compound Annual Growth Rate (CAGR) of 32.4 % during 2024–2029, according to a new report by MarketsandMarkets™.

Browse in-depth TOC on “LoRa and LoRaWAN IoT Market”
320 – Tables 58 – Figures294 – Pages
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144298529
Scope of the Report
Report Metrics
Details
Market size available for years
2018-2029
Base year considered
2023
Forecast period
2024–2029
Forecast units
Value (USD Billion)
Segments Covered
Offering, Network Deployment, Application, End User, and Region
Region covered
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.
List of Companies in LoRa and LoRaWAN IoT
The Bosch Group (Germany),  Cisco (US), Orange SA (France), Comcast Corporation (US), Semtech (US), NEC Corporation(Japan), Tata Communications (India), AWS (US), Advantech (Taiwan), SK Telecom (South Korea), Murata (Japan), Kerlink (France), Actility (France), Digi International (US), MultiTech (US), Ezurio (US), Sensoterra (Netherlands), Nwave Technologies (US), RAKwireless (China), TheThings.io (Spain), Datacake (Germany), Milesight (China), LORIOT (Switzerland), Exosite (US), Orbiwise (Switzerland), Netmore Group (Sweden), and Radio Bridge Inc (US).
The LoRaWAN ecosystem influences development of tools, software libraries, and cloud-based platforms that streamline the creation, deployment, and management of IoT solutions. Continuously evolving, this ecosystem boasts a burgeoning array of vendors providing LoRa-compliant devices, gateways, and network management solutions. This vibrant competition within the ecosystem propels innovation while driving down costs for end-users. Moreover, the development of interoperable solutions fosters seamless integration and deployment of LoRaWAN networks, simplifying the implementation process for businesses and organizations. As the ecosystem continues to expand and mature, it empowers developers, system integrators, and IoT enthusiasts to unleash their creativity, accelerate time-to-market, and unlock the full potential of LoRaWAN technology in diverse applications and industries.
Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=144298529
Based on network deployment, the public network segment to hold the largest market size during the forecast period.
The robust security features integrated into public LoRaWAN networks play a significant role in driving the growth and adoption of LoRaWAN technology in the market. End-to-end encryption ensures that data transmitted between devices and gateways is protected from unauthorized access or interception, safeguarding sensitive information such as sensor readings, location data, and command messages. Message integrity checks verify the integrity of data packets, detecting any tampering or alteration during transmission and ensuring data authenticity and reliability. Additionally, mutual authentication mechanisms establish trust between devices and gateways, verifying the identity of both parties before allowing communication to occur. These security measures provide organizations and end-users with confidence in the integrity and confidentiality of their data, mitigating concerns related to data privacy, cybersecurity threats, and regulatory compliance. As a result, implementing robust security features in public LoRaWAN networks enhances trust and credibility in the technology, driving increased adoption and market growth as organizations seek reliable and secure connectivity solutions for their IoT deployments.
By offering, the services segment is expected to hold a higher growth rate during the forecast period.
IoT service providers are pivotal in driving adoption by developing vertical-specific solutions finely tuned to the distinct needs of industries like agriculture, healthcare, logistics, and smart cities. In agriculture, for instance, IoT services offer solutions for precision farming, crop monitoring, and livestock management, enabling farmers to optimize irrigation, monitor soil health, and enhance yields. Similarly, IoT services facilitate remote patient monitoring, asset tracking, and inventory management in healthcare, improving patient care, reducing costs, and ensuring compliance with regulatory standards such as HIPAA. In logistics, IoT services provide real-time tracking of shipments, fleet management, and predictive maintenance, enhancing supply chain visibility, efficiency, and reliability. For smart cities, IoT services offer solutions for traffic management, waste management, energy optimization, and public safety, transforming urban infrastructure and enhancing the quality of life for residents. By addressing industry-specific challenges, compliance requirements, and use cases, vertical-specific IoT solutions deliver tangible business value, driving adoption and fueling the growth of the IoT services market across diverse sectors.
Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=144298529
Asia Pacific is expected to hold a higher growth rate during the forecast period.
In the Asia Pacific region, where agriculture serves as a cornerstone of many economies, adopting IoT technologies, particularly LoRa and LoRaWAN, is revolutionizing traditional farming practices. LoRaWAN’s long-range connectivity and low-power consumption make it well-suited for deployment in rural agricultural settings, where access to reliable connectivity may be limited. Through LoRa-based IoT solutions, farmers can implement precision agriculture techniques to address pressing challenges such as water scarcity, soil degradation, and unpredictable weather patterns. LoRa-enabled sensors facilitate real-time monitoring of soil moisture levels, temperature, and humidity, allowing farmers to optimize irrigation schedules and conserve water resources. Remote sensing technologies powered by LoRaWAN enable farmers to gather actionable insights on crop health, pest infestations, and nutrient deficiencies, facilitating timely interventions and improving overall crop management practices. Furthermore, LoRa-based crop analytics platforms provide farmers with data-driven decision support tools, helping them optimize planting strategies, improve yield forecasting, and mitigate the impact of climate change on agricultural productivity. By harnessing the power of LoRa and LoRaWAN IoT solutions, farmers in the Asia Pacific region can increase yields, conserve resources, and enhance resilience to environmental challenges, driving the adoption and growth of the LoRaWAN IoT market in the agricultural sector.
Top Key Companies in LoRa and LoRaWAN IoT Market:
The major vendors covered in the LoRa and LoRaWAN IoT Market are The Bosch Group (Germany),  Cisco (US), Orange SA (France), Comcast Corporation (US), Semtech (US), NEC Corporation(Japan), Tata Communications (India), AWS (US), Advantech (Taiwan), SK Telecom (South Korea), Murata (Japan), Kerlink (France), Actility (France), Digi International (US), MultiTech (US), Ezurio (US), Sensoterra (Netherlands), Nwave Technologies (US), RAKwireless (China), TheThings.io (Spain), Datacake (Germany), Milesight (China), LORIOT (Switzerland), Exosite (US), Orbiwise (Switzerland), Netmore Group (Sweden), and Radio Bridge Inc (US). These players have adopted various growth strategies, such as partnerships, agreements and collaborations, new product launches, enhancements, and acquisitions to expand their footprint in the LoRa and LoRaWAN IoT Market.
Browse Adjacent Markets: Digitalization and Internet of Things (IoT) Market Research Reports & Consulting
Related Reports:
Perimeter Security Market- Global Forecast to 2029
Smart Cities Market – Global Forecast to 2028
Fleet Management Market – Global Forecast to 2028
Smart Water Management Market – Global Forecast to 2028
Rail Asset Management Market – Global Forecast to 2026
Get access to the latest updates on LoRa and LoRaWAN IoT Companies and LoRa and LoRaWAN IoT Industry
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:Mr. Aashish MehraMarketsandMarkets™ INC.630 Dundee RoadSuite 430Northbrook, IL 60062USA: +1-888-600-6441Email: [email protected] Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg

View original content:https://www.prnewswire.co.uk/news-releases/lora-and-lorawan-iot-market-worth-32-7-billion-by-2029–exclusive-report-by-marketsandmarkets-302172905.html

Continue Reading

Trending